Savant Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $962K | Buy |
13,932
+403
| +3% | +$27.8K | 0.01% | 828 |
|
|
2025
Q1 | $939K | Sell |
13,529
-430
| -3% | -$29.9K | 0.01% | 776 |
|
|
2024
Q4 | $1.2M | Buy |
13,959
+1,640
| +13% | +$141K | 0.01% | 585 |
|
|
2024
Q3 | $1.47M | Sell |
12,319
-268
| -2% | -$31.9K | 0.01% | 519 |
|
|
2024
Q2 | $1.8M | Buy |
12,587
+1,751
| +16% | +$250K | 0.02% | 411 |
|
|
2024
Q1 | $1.39M | Buy |
10,836
+507
| +5% | +$65.1K | 0.02% | 451 |
|
|
2023
Q4 | $1.07M | Sell |
10,329
-251
| -2% | -$26K | 0.01% | 401 |
|
|
2023
Q3 | $962K | Buy |
10,580
+506
| +5% | +$46K | 0.01% | 393 |
|
|
2023
Q2 | $815K | Buy |
10,074
+294
| +3% | +$23.8K | 0.01% | 420 |
|
|
2023
Q1 | $778K | Buy |
9,780
+550
| +6% | +$43.8K | 0.01% | 377 |
|
|
2022
Q4 | $571K | Buy |
9,230
+2,142
| +30% | +$133K | 0.01% | 342 |
|
|
2022
Q3 | $353K | Sell |
7,088
-422
| -6% | -$21K | 0.01% | 398 |
|
|
2022
Q2 | $418K | Sell |
7,510
-244
| -3% | -$13.6K | 0.01% | 372 |
|
|
2022
Q1 | $431K | Sell |
7,754
-486
| -6% | -$27K | 0.01% | 383 |
|
|
2021
Q4 | $461K | Buy |
+8,240
| New | +$461K | 0.01% | 370 |
|